Document is current
Any future updates will be listed below
-
Authors
McManus, R. J.
Smith, A.
Temple, E.
Yu, L. M.
Allen, J.
Doogue, R.
Ford, G. A.
Glynn, L.
Guthrie, B.
Hall, P.
Hinton, L.
Hobbs, F. D. R.
Mant, J.
McKinstry, B.
Mead, G.
Morton, K.
Rai, T.
Rice, C.
Roman, C.
Stoddart, A.
Tarassenko, L.
Velardo, C.
Williams, M.
Yardley, L.
,
- License Information
-
More Information
Article History
Received: 24 May 2024
Accepted: 4 November 2024
First Online: 27 December 2024
Declarations
:
: Ethical approval was granted by North West - Greater Manchester East Research Ethics Committee Reference 19/NW/0409.Written informed consent was obtained before eligibility confirmation.
: Not applicable.
: RM has received BP monitors for research from Omron (which were recycled for use in the current study) and Oxford University has received fees and consultancy from Omron for his work. FDRH has received occasional fees or expenses for speaking or consultancy from AZ, BI, Bayer, BMS/Pfizer, and Novartis. BM has received consultancy fees from the Scottish Government for advice on remote monitoring of hypertension. CRo has received consultancy fees from Sensyne Health for work on telemonitoring products. The other authors declare no further conflicts of interest.
